MANAURY ALVARADO PONCE: Open Payments
NPI 1184475212 · ARLINGTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$430 in 24 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $1,235 · 2025 $430
Food & beverage: $430
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $164 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $64 |
| Celltrion USA Inc. | 2 | $40 |
| PFIZER INC. | 2 | $39 |
| Aimmune Therapeutics, Inc. | 2 | $36 |
| Ardelyx, Inc. | 1 | $27 |
| Novo Nordisk Inc | 1 | $24 |
| Madrigal Pharmaceuticals | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
Products named: CREON, ENTYVIO, VIBERZI, RINVOQ, VEGZELMA, VELSIPITY, ZENPEP, IBSRELA.
Industry payments across TX — which companies pay providers there.
